INTRODUCTION {#S1}
============

Primary care settings face multiple challenges in attempting to provide care. Those practices that serve underserved populations are especially challenged not only to provide comprehensive care, but to also provide additional supportive resources to make care possible. Interdisciplinary teams in the primary care setting are a valuable resource in providing those additional supportive resources. Part of the interdisciplinary team that is a necessary component of practice offerings is pharmacy services. The role of the pharmacist has been evolving and growing to include more than just dispensing medicines and providing medication information at the local drug store. There is literature to substantiate the growing need for partnership between community providers and pharmacists and the role pharmacists can play in enhancing patient compliance and outcomes.[@B1] Community pharmacy has become an integrated entity and the relationship between the pharmacist and physician has been recognized and is being appreciated and nurtured. Within the evolvement of the role of pharmacy, a shift is not only seen in the community, but in the academic setting as well. As an underserved practice that is part of a large academic center, cross disciplinary care not only provides enhanced offerings for patients but a learning environment for students from multiple disciplines. Pharmacy services are offered in our underserved setting through the academic institution's college of pharmacy and pharmacy staff includes a faculty member, resident and students. This team provides patient education and co-management through hour long patient visits with real time discussions with the patient's provider. Pharmacy services include medication review, diabetes education and management, lipid, anticoagulation and hypertension management and any other service related to medications. These visits, in contrast to the 15 and 30 minute visits the practitioners spend with the patients, are valuable and focused and provide added time for needed assessment. There is data to show that when pharmacy assists the physician in chronic disease management, better outcomes can be achieved.[@B2]-[@B11] A lipid study conducted by pharmacists in a clinical setting in South Carolina demonstrated favorable LDL reductions in enrollees where pharmacists played an active role in lipid management.[@B12] This model went as far as allowing the pharmacists to prescribe statin therapy and direct changes based on lab review. Our structure permits lab review and recommendation by the pharmacist, however, medication prescribing continues to be by the patient's physician.

In our primary care setting of pharmacy partnership we have seen improved outcomes with respect to chronic disease management. This article will further define this relationship in addition to sharing diabetes and hypertension outcomes of this collaboration. The objective of this study was to compare hemoglobin A1c and blood pressure measurements before and after pharmacy services were consulted. The post-pharmacy consultation markers were then compared to national goal averages in both disease categories.

METHODS {#S2}
=======

Participants {#S3}
------------

The family practice clinic averages a total of 12,000 patient visits annually. Sixty-two percent of those visits are within family practice and 38% are pediatric. Females comprise 61% of the patient population. The ethnicity breakdown includes 70% African Americans, 23% Caucasians, and 7% Hispanic. The clinic serves a predominantly low-income and medically underserved patient population. [Figure 1](#F1){ref-type="fig"} shows that half of the population at the described family practice are Medicaid patients and more than one out of ten patients are self-pay.

![Payor mix of all patients treated at the family practice.](pharmpract-07-248-g001){#F1}

Data was collected on patients with type 2 diabetes and/or hypertensive patients followed by the pharmacy service at the family practice clinic. Patients 18 years or older who were able to be followed prior to and subsequent to referral for pharmacy service by primary providers were included in our evaluation. A1C change was retrospectively tracked for twenty-two patients with type 2 diabetes, and blood pressure change was tracked for thirty patients with type 2 diabetes and/or hypertension (83% of patients evaluated for blood pressure had diabetes).

Intervention {#S4}
------------

A pharmacy residency director, an ambulatory care pharmacy resident and three fourth year student pharmacists on advanced pharmacy practice experiences (APPEs) work directly with physicians, nurse practitioners, nurses, and social workers to form an interdisciplinary health care team. Family practice providers utilize pharmacy service through pharmacist-run clinic referrals and/or pharmacy team consultations during regular physician visits. Providers may refer patients for a one-hour pharmacy clinic visit when the patient's disease states and/or medications need to be better controlled and require extensive monitoring and/or patient education. Pharmacotherapy management clinics are primarily provided for patients with polypharmacy, new diagnoses, uncontrolled chronic disease, and/or multiple comorbid conditions. Pharmacist-run clinics at this community practice include diabetes, hypertension, hyperlipidemia, anticoagulation, and medication management. The pharmacy service sees the patient for clinic visits that are distinct from their general provider visits. The referred patients are continuously monitored by both the pharmacy service and provider as separate clinic visits. However, all drug therapy and lifestyle recommendations during a pharmacy clinic visit are authorized by and signed off on by the patient's primary provider. Also, a pharmacy clinic visit patient note is added to the patient's chart, thus aiding the continuity of care. Time between both pharmacy and provider clinic visits varies depending upon the status of each patient's disease states. The pharmacy service at our clinic averages approximately 90 one-hour clinic visits per month. Each visit includes:

Clinical interview focused on disease(s) and medications: Diet/exercise, alcohol/tobacco/illicit drug use, family history, recent medication changes, missed/doubled medication doses (including pharmacy refill histories), adverse effects experienced, food and drug allergies, family history, signs/symptoms of specified disease(s), self-monitoring of blood glucose (SMBG) and/or home blood pressure readings, compliance with daily foot exams and annual eye exams, and thorough medication reconciliation.Point of care testing is performed \[blood pressure, blood glucose and/or international normalized ratio (INR)\]Medication counselingDisease state and diet/exercise counselingEvaluation of medication regimen: drug interactions, adverse events, laboratory values \[often fasting lipid panel, A1C, complete or basic metabolic panel (CMP or BMP), thyroid stimulating hormone (TSH), creatine kinase (CK)\]Recommendations for changes of medication regimenPatient medication list provided for patient and chart

Pharmacy team consultations are operated differently than pharmacy clinic referrals. Consultations are generally obtained when a provider visits the pharmacy office during their patient visit and inquires about a particular drug issue. These medication issues often need to be resolved while the patient remains in the clinic.

However, instances can arise in which the issue must be worked on by the pharmacy team for longer periods of time. Examples of pharmacy consultations include inquiries on drug therapy recommendations for patients on multiple medications or with comborbid conditions, drug side effects, drug interactions, drug indications and contraindications, drug dosing (including renal, hepatic, elderly, and pediatric), pharmacy refill histories, drug formulary management, and patient medication counseling.

The pharmacy service also handles all incoming patient medication concerns and questions (via phone or in the clinic during a provider visit), prior-authorizations (via fax from patient's pharmacy, per provider, or per patient), and prescription refill requests (per patient, per provider, or via pharmacy fax). The pharmacy service averages 40 refills, prior authorizations, and/or medication questions per day.

Additional Pharmacy Services Provided:

Drug informationPharmacotherapy consultationGlucose meter demonstration and trainingMedication administration demonstration and training (including insulin, inhalers, nasal sprays, and oral medications)Drug sample management and storage within the pharmacy service officeDrug samples are obtained via pharmaceutical industries and their representatives. Also, patient assistance programs (PAPs) are utilized through the onsite social worker. Drug samples and PAPs are dispensed by the pharmacy when ordered per a provider and medication counseling is performed. Drug samples may be provided to patients in financial hardships, when beginning a new medication in which there are samples available, or when a patient needs a trial of a medication to be changed or newly initiated. PAPs are provided for the patients with financial hardships and are often income restricted.Counsel on all psychiatric medications if newly initiated/changed, stopped abruptly before recommended trial period and/or if side effects experiencedManage the use of an ambulatory blood pressure monitor to better evaluate resistant hypertension, "white coat" hypertension, fluctuating blood pressures, etc.Administrate the Eastside Cares Program as a medication assistance aid for patients during financial hardshipsPatients that cannot afford their prescription copays or USD4 generic prescriptions offered by various retail pharmacies, may be provided with vouchers to obtain these medications for free. Voucher funding is provided through sponsor donations to the family practice clinic.

Endpoints {#S5}
---------

Two primary endpoints were evaluated in this data collection: Hemoglobin A1c (A1C in mg/dL) to assess glycemic control and blood pressure (mmHg). These markers were retrospectively evaluated via patient charts. Patient charts needed to be easily accessible to evaluate each endpoint. Accessibility to charts was based on how long the patient had been at the family practice; the longer a patient's history with the practice, the more likely older chart volumes were located in an unavailable and secure storage unit. A1C was tracked immediately prior to pharmacy referral at the previous physician visit, 3 to 6 months after referral while followed by pharmacy, and at least 6 months later at the most current measure. The mean A1C, mean A1C change, and percent at the American Diabetes Association (ADA) goal (A1C\<7%) were calculated.[@B13] Blood pressure was followed directly prior to pharmacy referral at the previous physician visit, 2 to 4 months after pharmacy referral while followed by pharmacy, and at least 4 months later at the most current measure. The mean blood pressure and percentage at the Seventh Report of the Joint National Commission of hypertension (JNC-7) goal (\<140/90mmHg versus \<130/80mmHg for patients with diabetes) were calculated.[@B14] The mean percentage at goal for each current marker was then compared to the national averages at goal.

Data Analysis {#S6}
-------------

No statistical analyses were performed to evaluate the data obtained; only direct comparisons to the national averages as percentages at goal were conducted.

RESULTS {#S7}
=======

Hemoglobin A1c {#S8}
--------------

A total of twenty-two patients were evaluated for glycemic control per A1C. [Figure 2](#F2){ref-type="fig"} shows the mean A1C for the followed patients with diabetes before referral to pharmacy service was 9.8%; at 3 to 6 months following initiation of pharmacy service the mean was 8.4%; and the most current mean value at an average of 15.5 months (ranging 6 to 50 months) with the service was 7.7%. The overall mean change in A1C was 2.1% with 1.5% at 3 to 6 months and 0.7% after at least 6 months.
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50% of patients met the ADA recommended A1C goal of less than 7% at their most current value.[@B13]

This percent correlates well with the most recent National Health and Nutrition Examination Survey (NHANES) for 1999-2002 data revealing a national average of 49.8% US adults with diabetes are at goal. This national average is even lower in the African American population at approximately 44%; 70% of patients treated at the family practice are African American.[@B15] (See [Table 1](#T1){ref-type="table"})

###### 

Comparison of percentages of A1C and blood pressures at goal with our pharmacy service to the national averages

  ----------------- ------------------------------- -------------------------------------------------
  Marker and Goal   At goal with Pharmacy Service   NHANES National averages at goal in adults15,16
  A1C \< 7.0%       50%                             49.8% (44% in African Americans)
  BP                                                
  \<140/90mmHg or   30%                             33.1% (\<140/90mmHg)
  \<130/80mmHg                                      33.2% (\<130/80mmHg)
  ----------------- ------------------------------- -------------------------------------------------

Blood Pressure {#S9}
--------------

Thirty patients were evaluated for blood pressure control. 85% of blood pressure evaluations were performed in patients with diabetes who were at a goal of less than 130/80mmHg per JNC-7 guidelines. The remaining 15% of blood pressure evaluations were at the less than 140/90mmHg goal.[@B14] [Figure 3](#F3){ref-type="fig"} shows the mean blood pressure before pharmacy service, at 158/90mmHg; 2 to 4 months after initiating the service, the mean was 128/81mmHg; and at least 4 months following the use of pharmacy services, the most current mean blood pressure was calculated at 132/78mmHg. Thirty percent of patients were at their blood pressure goal at the most current level measured at an average of 11.1 months (ranging 4 to 30 months) after initiating pharmacy services. Nationally, 33.1% of patients without diabetes and 33.2% of patients with diabetes have met their blood pressure goal per NHANES 1999-2004.[@B16] (See [Table 1](#T1){ref-type="table"})
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DISCUSSION {#S10}
==========

The most current best practices in many of the chronic diseases managed in the primary care setting, especially diabetes and hypertension, require utilization of polypharmacy.[@B13],[@B14] A collaborative approach may be needed for the management of multiple medications and these chronic illnesses, especially in a medically underserved patient population. Recent supportive data in a similar practice setting as ours adhered to ADA recommendations. Pharmacy medication management significantly improved glycemic control while maintaining weight and blood pressure.[@B10] The purpose of our article is to provide a description of an interdisciplinary model incorporating pharmacy services into the medical management of chronic disease states within a unique family practice setting.

According to a 2004 national American Society of Health-System Pharmacists (ASHP) survey of ambulatory care pharmacy practice, the roles and responsibilities of pharmacists are continuously evolving, especially in the Veterans Affairs (VA) system. Over 50% of the organizations surveyed reported pharmacist-run medication management programs.[@B8] Multiple similar models of pharmaceutical care services have been implemented and show promising outcomes that have been described in the literature.[@B2]-[@B11] In a nonrandomized, prospective VA trial of a clinical pharmacist-managed diabetes clinic, a significant improvement was seen in A1C from a mean of 10.3% to 6.9% over 9 to 12 months (p\<0.001). Secondary endpoints of systolic and diastolic blood pressure along with LDL were also reduced (p\<0.001).[@B3] The Asheville Project, based out of North Carolina, offered a community-based pharmacy diabetes program in collaboration with physicians. Short-term and long-term clinical outcomes showed significant improvement in A1C values, sick days used were reduced, and employers saved on insurance expenditures.[@B4],[@B5] Two trials, one retrospective and one observational, of patients involved in a diabetes management program under a collaborative practice agreement, showed a significant reduction in A1C and blood pressure, increased the percentage of patients at the ADA's A1C goal, and improved adherence to daily aspirin therapy.[@B7],[@B11] We have also provided data on clinical outcomes of glycemic and blood pressure control under the umbrella of a pharmacy referral system. Achievement of outcomes were obtained through detailed interviews, patient education, medication reviews, laboratory reviews, and recommended dosing changes. Our project was carried out retrospectively and was reliant on charts for review. Accessibility to charts limited the number of patients observed. The longer a patient's history with the practice, the more likely older chart volumes were located in an unavailable and secure storage unit. Discrepancies in documentation, as well as, variability in frequency of laboratory testing should be considered. Various styles of documentation and vital sign attainment between health care workers (i.e. physician, nurses, medical assistants) in a single patient chart may produce discrepancies in the outcome markers observed. Also, laboratory testing frequency varies depending on patient-specific disease state control and patient willingness/affordability to obtain the recommended labs. Although the blood pressure data was not an improvement over the national averages at goal, it was comparable and reflects an underserved community. Measurement bias due to multiple different health care workers obtaining blood pressures, as decribed above, may have skewed collected data. Also, patients' diabetes or hypertension pharmacotherapy regimens, as well as years with each disease, were not addressed. The time from most current marker obtained and the beginning of pharmacy services was highly variable at 4 to 30 months (11.1 month mean) for blood pressure values and 6 to 50 months (15.5 month mean) for A1C values. This variability was attributable to an extensive history with the pharmacy service and/or a low clinic appointment show rate. This current value was obtained in an attempt to reflect the maintainability of the health outcome measures. More detailed tracking of the disease markers throughout the patients' history with pharmacy service could have altered the outcomes observed. Our data was compared to national averages, as was a previous trial which attained treatment goals more often than the national average and improved retinal and microalbumin screening rates.

The primary goal of a pharmacy partnership in the family practice setting is to improve the health outcomes of our patients. Our data suggests success within this partnership to serve a medically underserved community and points us in the direction of multidisciplinary chronic disease state management models as a mainstay in primary care. Pharmacy services in the family practice setting allow for more intense counseling on medications while providers are able to focus on patients' other health concerns.

CONCLUSIONS {#S11}
===========

The medically underserved patients under the care of pharmacy services achieved a higher percentage at their hemoglobin A1c goal than the national mean. The percentage of patients who achieved their blood pressure goals was comparable to the national average at goal. Increasing utilization of pharmacy services in the family practice setting allows for pharmacists and providers to form a trusted relationship that broadens each practitioner's knowledge while providing enhanced care and potentially improved outcomes for patients.
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